These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23024263)

  • 21. Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.
    Muratsu J; Iwabayashi M; Sanada F; Taniyama Y; Otsu R; Rakugi H; Morishita R
    Sci Rep; 2017 Mar; 7(1):130. PubMed ID: 28273932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
    Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
    Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor ameliorates hyperglycemia and corrects β-cell mass in IRS2-deficient mice.
    Alvarez-Perez JC; Rosa TC; Casinelli GP; Valle SR; Lakshmipathi J; Rosselot C; Rausell-Palamos F; Vasavada RC; García-Ocaña A
    Mol Endocrinol; 2014 Dec; 28(12):2038-48. PubMed ID: 25361392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
    Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
    Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.
    Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS
    Carcinogenesis; 2014 Aug; 35(8):1891-900. PubMed ID: 24876152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
    Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway.
    Zhang YY; Li C; Yao GF; Du LJ; Liu Y; Zheng XJ; Yan S; Sun JY; Liu Y; Liu MZ; Zhang X; Wei G; Tong W; Chen X; Wu Y; Sun S; Liu S; Ding Q; Yu Y; Yin H; Duan SZ
    Diabetes; 2017 Jun; 66(6):1535-1547. PubMed ID: 28325853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance.
    Liang H; Yin B; Zhang H; Zhang S; Zeng Q; Wang J; Jiang X; Yuan L; Wang CY; Li Z
    Endocrinology; 2008 Jun; 149(6):2943-51. PubMed ID: 18339717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity.
    Tyndall SJ; Walikonis RS
    Synapse; 2007 Apr; 61(4):199-204. PubMed ID: 17230549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism.
    Fafalios A; Ma J; Tan X; Stoops J; Luo J; Defrances MC; Zarnegar R
    Nat Med; 2011 Nov; 17(12):1577-84. PubMed ID: 22081023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
    Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer.
    Yamada T; Matsumoto K; Wang W; Li Q; Nishioka Y; Sekido Y; Sone S; Yano S
    Clin Cancer Res; 2010 Jan; 16(1):174-83. PubMed ID: 20008840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.
    González-Pertusa JA; Dubé J; Valle SR; Rosa TC; Takane KK; Mellado-Gil JM; Perdomo G; Vasavada RC; García-Ocaña A
    Endocrinology; 2010 Apr; 151(4):1487-98. PubMed ID: 20176723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes.
    Coudriet GM; Stoops J; Orr AV; Bhushan B; Koral K; Lee S; Previte DM; Dong HH; Michalopoulos GK; Mars WM; Piganelli JD
    Am J Pathol; 2019 Jul; 189(7):1413-1422. PubMed ID: 31054988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.
    Sundaram S; Freemerman AJ; Johnson AR; Milner JJ; McNaughton KK; Galanko JA; Bendt KM; Darr DB; Perou CM; Troester MA; Makowski L
    Breast Cancer Res Treat; 2013 Dec; 142(3):489-503. PubMed ID: 24218051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving islet transplantation by gene delivery of hepatocyte growth factor (HGF) and its downstream target, protein kinase B (PKB)/Akt.
    Fiaschi-Taesch N; Stewart AF; Garcia-Ocaña A
    Cell Biochem Biophys; 2007; 48(2-3):191-9. PubMed ID: 17709889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.